✨
AI Summary
- Arialys Therapeutics CEO discusses autoimmune neuropsychiatry.
- Focus on monoclonal antibody for anti-NMDA receptor encephalitis.
- Potential for treating rare autoimmune neurological conditions.
Guests on This Episode
PF
Peter Flynn
1 podcast appearance